Press Releases

October 15, 2018 Lupin receives tentative FDA approval for generic Lurasidone Hydrochloride Tablets, 20 mg, 40 mg, 60 mg, 80 mg and 120 mg

October 13, 2018 Lupin Quarter II, FY2019 – Results

October 9, 2018 Lupin launches generic Clobetasol Propionate Ointment USP 0.05% in the US

October 4, 2018 Lupin launches generic Potassium Chloride Oral Solution USP, 20 mEq/15mL (10%) and 40 mEq/15 mL (20%)

September 18, 2018 Lupin appoints Alok Sonig as CEO – US Generics and Global Head – Generics R&D & Biosimilars

September 17, 2018 Lupin appoints Dr. Kamal K. Sharma as Advisor to the Company

September 14, 2018 Lupin’s Nagpur facility inspection by US FDA concluded with no observation

September 12, 2018 Lupin receives FDA approval for generic Atovaquone Oral Solution USP

September 4, 2018 Lupin’s Tarapur API Manufacturing Facility Inspected by US FDA